JAWS and the 2023 Hall of Fame Ballot: Jhonny Peralta

The following article is part of Jay Jaffe’s ongoing look at the candidates on the BBWAA 2023 Hall of Fame ballot. For a detailed introduction to this year’s ballot, and other candidates in the series, use the tool above; an introduction to JAWS can be found here. For a tentative schedule, and a chance to fill out a Hall of Fame ballot for our crowdsourcing project, see here. All WAR figures refer to the Baseball-Reference version unless otherwise indicated.
Player | Pos | Career WAR | Peak WAR | JAWS | H | HR | SB | AVG/OBP/SLG | OPS+ |
---|---|---|---|---|---|---|---|---|---|
Jhonny Peralta | SS | 30.4 | 26.5 | 28.5 | 1,761 | 202 | 17 | .267/.329/.423 | 102 |
A bat-first shortstop with some pop and a first name that some writers interpreted as a typographical error, Jhonny Peralta spent 15 seasons in the majors (2003-17) while helping all three franchises he played for — Cleveland, Detroit and St. Louis — make the playoffs at least once. Though he struggled in his first exposure to the majors, he soon supplanted longtime fan favorite Omar Vizquel, impressing teammates and executives with his poise and establishing himself as part of a contending club’s youthful core.
Peralta made three All-Star teams, all in his late 20s and early 30s, though his career was tarnished due to a 50-game suspension for receiving performance-enhancing drugs from Biogenesis, the Miami-based anti-aging clinic whose most famous baseball client, Alex Rodriguez, received a full-season suspension. That Peralta was able to return to the Tigers in time to participate in their 2013 playoff run, and that he signed the biggest contract of his career shortly afterwards, caused controversy within the game and played a part in increasing PED penalties — which might be the most lasting part of his legacy. Read the rest of this entry »